RecruitingNCT05504057
Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection
Studying Acute motor axonal neuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Consorci Sanitari de Terrassa
- Principal Investigator
- Anna Puigdellívol, PhDTerrassa Health Consortium
- Intervention
- Antihistamine(drug)
- Enrollment
- 140660 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2028
Study locations (2)
- Hospital de Terrassa, Terrassa, Barcelona, Spain
- Hospital of Terrassa, Terrassa, Barcelona, Spain
Collaborators
Institut Català de la Salut
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05504057 on ClinicalTrials.govOther trials for Acute motor axonal neuropathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07421427Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain SyndromeCairo University
- ACTIVE NOT RECRUITINGPHASE2NCT06253923Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).SHINKEI Therapeutics, Inc
- RECRUITINGPHASE2NCT05140148Promoting Recovery After STroke With AmantadineUniversity of Pennsylvania
- RECRUITINGNCT04367883Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 InfectionConsorci Sanitari de Terrassa
- ACTIVE NOT RECRUITINGPHASE2NCT06443827Effect of Intravenous Amantadine Sulphate on Disorders of ConsciousnessAzienda Sanitaria dell'Alto Adige